Jonathan Violin, Chief Executive Officer at Viridian Therapeutics, Inc.\DE (VRDN), sold 56,400 shares at $18.92 ($1.1M) on 2022-04-01, disclosed to the SEC on 2022-04-05.
Open-market sale of $1.1M VRDN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.92 | 26,400 | $499K | 46.8% |
| 2 | $18.92 | 26,400 | $499K | 46.8% |
| 3 | $18.93 | 3,600 | $68K | 6.4% |
| Total | $18.92 avg | 56,400 | $1.1M | 100% |
| Filing → |
| VRDN | SELL | 2022-05-04 | $391K | — | Filing → |
| VRDN | SELL | 2022-03-03 | $1.1M | — | Filing → |
| VRDN | SELL | 2022-02-03 | $1.1M | — | Filing → |